Neuromyelitis Optica Spectrum Disorder Market Report 2026
Download Free Sample Buy Now
Neuromyelitis Optica Spectrum Disorder Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Neuromyelitis Optica Spectrum Disorder Market Report 2026

Global Outlook – By Type (Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies, Neuromyelitis Optica Spectrum Disorder Without Aquaporin-4 Antibodies), By Diagnosis (Imaging Tests, Magnetic Resonance Imaging (MRI), Blood Tests, Other Diagnosis), By Treatment Type (C5 Protein Inhibitor, Monoclonal Antibodies, Plasma Exchange Therapy, Corticosteroids, Immunoglobulin Therapy, Medication, Other Treatment Types), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Neuromyelitis Optica Spectrum Disorder Market Overview

• Neuromyelitis Optica Spectrum Disorder market size has reached to $2.54 billion in 2025

• Expected to grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%

• Growth Driver: Rising Multiple Sclerosis Cases Fueling The Growth Of The Market Due To Improved Diagnostics And Increased Awareness

• Market Trend: Advancements In Complement Inhibition Transform NMOSD Treatment Landscape

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neuromyelitis Optica Spectrum Disorder Market?

Neuromyelitis optica spectrum disorder (NMOSD) is a rare, autoimmune disease that affects the central nervous system, primarily targeting the spinal cord and optic nerves. It is characterized by severe inflammation and demyelination (damage to the protective covering of nerve fibers) in these areas, leading to symptoms such as vision loss, paralysis, and loss of sensory function.

The main types of neuromyelitis optica spectrum disorder are neuromyelitis optica spectrum disorder with aquaporin-4 antibodies and neuromyelitis optica spectrum disorder without aquaporin-4 antibodies. Neuromyelitis optica spectrum disorder with aquaporin-4 antibodies occurs when the immune system attacks nerve fibers, causing inflammation, vision loss, and paralysis. It is diagnosed by several diagnoses, such as imaging tests, magnetic resonance imaging (MRI), blood tests, and others, and it is treated with several treatment types, including C5 protein inhibitors, monoclonal antibodies, plasma exchange therapy, corticosteroids, immunoglobulin therapy, medication, and others. It is distributed through various distribution channels such as hospital pharmacy, retail pharmacy, and online pharmacy and is used by several end-users, including hospitals, specialty clinics, home care, and others.

Neuromyelitis Optica Spectrum Disorder Market Global Report 2026 Market Report bar graph

What Is The Neuromyelitis Optica Spectrum Disorder Market Size and Share 2026?

The neuromyelitis optica spectrum disorder market size has grown strongly in recent years. It will grow from $2.54 billion in 2025 to $2.76 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing awareness of nmosd, early development of immunosuppressive treatments, initial use of corticosteroids for flare control, adoption of imaging for differential diagnosis, rising identification of aqp4 antibodies.

What Is The Neuromyelitis Optica Spectrum Disorder Market Growth Forecast?

The neuromyelitis optica spectrum disorder market size is expected to see strong growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing demand for targeted biologics, increasing development of mog-antibody therapies, expansion of advanced diagnostic platforms, rising investment in autoimmune research, development of next-generation immunotherapy solutions. Major trends in the forecast period include increasing adoption of monoclonal antibody therapies, rising use of advanced imaging techniques for early diagnosis, growing demand for plasma exchange and immunoglobulin therapy, expansion of aqp4-positive and mog-antibody testing, increasing focus on relapse prevention and long-term disease management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Neuromyelitis Optica Spectrum Disorder Market Segmentation

1) By Type: Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies, Neuromyelitis Optica Spectrum Disorder Without Aquaporin-4 Antibodies

2) By Diagnosis: Imaging Tests, Magnetic Resonance Imaging (MRI), Blood Tests, Other Diagnosis

3) By Treatment Type: C5 Protein Inhibitor, Monoclonal Antibodies, Plasma Exchange Therapy, Corticosteroids, Immunoglobulin Therapy, Medication, Other Treatment Types

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies: Relapsing NMOSD With AQP4-IgG, Monophasic NMOSD With AQP4-IgG, Severe Optic Neuritis With AQP4-IgG, Longitudinally Extensive Transverse Myelitis (LETM) With AQP4-IgG

2) By Neuromyelitis Optica Spectrum Disorder Without Aquaporin-4 Antibodies: NMOSD With Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies (MOG-IgG), Seronegative NMOSD, Idiopathic NMOSD Cases, NMOSD Associated With Other Autoimmune Disorders

What Is The Driver Of The Neuromyelitis Optica Spectrum Disorder Market?

The increasing prevalence of multiple sclerosis is expected to propel the growth of the neuromyelitis optica spectrum disorder market going forward. Multiple sclerosis is a chronic autoimmune disease affecting the central nervous system, causing inflammation, nerve damage, and neurological symptoms. The increasing prevalence of multiple sclerosis is due to improvising diagnostic techniques, environmental influences, and genetic predisposition. Advancements in medical imaging, such as MRI, have allowed for earlier and more accurate diagnoses, leading to an apparent rise in cases. As more individuals are diagnosed with MS, there is a heightened awareness of neurological autoimmune diseases, leading to improved diagnostic methods and greater recognition of neuromyelitis optica spectrum disorder. For instance, in May 2024, according to the Multiple Sclerosis Trust, a UK-based national charity, the UK sees approximately 7,100 new multiple sclerosis cases annually, and some 135 persons are diagnosed with MS each week. Therefore, the increasing prevalence of multiple sclerosis drives the growth of the neuromyelitis optica spectrum disorder industry.

Key Players In The Global Neuromyelitis Optica Spectrum Disorder Market

Major companies operating in the neuromyelitis optica spectrum disorder market are F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holding, Chugai Pharmaceutical Co. Ltd, Mayo Foundation for Medical Education and Research, Penn Medicine, Genentech Inc, Oregon Health & Science University, Arup Laboratories, Argenx SE, Metropolis Healthcare, Rush University Medical Center, Mitsubishi Tanabe Pharma Corporation, Viela Bio, Alexion Pharmaceuticals, Horizon Therapeutics plc, UCB S.A, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi S.A, Pfizer Inc, Eli Lilly and Company, Immune Pharmaceuticals Inc.

Global Neuromyelitis Optica Spectrum Disorder Market Trends and Insights

Major companies operating in the neuromyelitis optica spectrum disorder market are focusing on developing innovative products, such as long-acting complement inhibitors, to enhance treatment efficacy and improve patient outcomes. Long-acting complement inhibitors are treatments that suppress the complement system for an extended duration, preventing inflammation and nerve damage in neuromyelitis optica spectrum disorder (NMOSD). They help minimize relapses and support long-term disease control. For instance, in March 2024, Alexion Pharmaceuticals, a US-based biopharmaceutical company, and AstraZeneca, a UK-based pharmaceutical industry, received approval for ULTOMIRIS (ravulizumab-cwvz) for the treatment of adults with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD). This approval marks Ultomiris as the first and only long-acting C5 complement inhibitor available for NMOSD treatment. The decision was based on the Phase III CHAMPION-NMOSD trial, where Ultomiris demonstrated a 98.6% reduction in relapse risk over 73 weeks compared to a placebo. Trial participants experienced no relapses, and no new safety concerns were identified.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Neuromyelitis Optica Spectrum Disorder Market?

In October 2023, Amgen, a US-based biotechnology company, acquired Horizon Therapeutics plc for $27.8 billion. With this acquisition, Amgen expands its portfolio in the rare disease and autoimmune disease market, strengthening its position with first-in-class treatments such as UPLIZNA (ibalizumab-con) for neuromyelitis optica spectrum disorder (NMOSD) for adult patients who are anti-aquaporin-4 (AQP4) antibody positive. Horizon Therapeutics plc is an Ireland-based biotechnology company that provides treatment of neuromyelitis optica spectrum disorder.

Regional Outlook

North America was the largest region in the neuromyelitis optica spectrum disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neuromyelitis Optica Spectrum Disorder Market?

The neuromyelitis optica spectrum disorder market consists of revenues earned by entities by providing services such as rehabilitation services, patient assistance programs, and intravenous immunoglobulin (IVIG) therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuromyelitis optica spectrum disorder market includes sales of immunosuppressants, corticosteroids, and symptomatic treatments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neuromyelitis Optica Spectrum Disorder Market Report 2026?

The neuromyelitis optica spectrum disorder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neuromyelitis optica spectrum disorder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neuromyelitis Optica Spectrum Disorder Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.76 billion
Revenue Forecast In 2035 $3.76 billion
Growth Rate CAGR of 8.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Diagnosis, Treatment Type, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holding, Chugai Pharmaceutical Co. Ltd, Mayo Foundation for Medical Education and Research, Penn Medicine, Genentech Inc, Oregon Health & Science University, Arup Laboratories, Argenx SE, Metropolis Healthcare, Rush University Medical Center, Mitsubishi Tanabe Pharma Corporation, Viela Bio, Alexion Pharmaceuticals, Horizon Therapeutics plc, UCB S.A, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi S.A, Pfizer Inc, Eli Lilly and Company, Immune Pharmaceuticals Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neuromyelitis Optica Spectrum Disorder Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neuromyelitis Optica Spectrum Disorder Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neuromyelitis Optica Spectrum Disorder Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neuromyelitis Optica Spectrum Disorder Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Monoclonal Antibody Therapies

4.2.2 Rising Use Of Advanced Imaging Techniques For Early Diagnosis

4.2.3 Growing Demand For Plasma Exchange And Immunoglobulin Therapy

4.2.4 Expansion Of Aqp4-Positive And Mog-Antibody Testing

4.2.5 Increasing Focus On Relapse Prevention And Long-Term Disease Management

5. Neuromyelitis Optica Spectrum Disorder Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Providers

5.4 Research & Academic Centers

5.5 Diagnostic Laboratories

6. Neuromyelitis Optica Spectrum Disorder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuromyelitis Optica Spectrum Disorder Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neuromyelitis Optica Spectrum Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neuromyelitis Optica Spectrum Disorder Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neuromyelitis Optica Spectrum Disorder Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neuromyelitis Optica Spectrum Disorder Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuromyelitis Optica Spectrum Disorder Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuromyelitis Optica Spectrum Disorder Market Segmentation

9.1. Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies, Neuromyelitis Optica Spectrum Disorder Without Aquaporin-4 Antibodies

9.2. Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imaging Tests, Magnetic Resonance Imaging (MRI), Blood Tests, Other Diagnosis

9.3. Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

C5 Protein Inhibitor, Monoclonal Antibodies, Plasma Exchange Therapy, Corticosteroids, Immunoglobulin Therapy, Medication, Other Treatment Types

9.4. Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

9.5. Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare, Other End-Users

9.6. Global Neuromyelitis Optica Spectrum Disorder Market, Sub-Segmentation Of Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Relapsing NMOSD With AQP4-IgG, Monophasic NMOSD With AQP4-IgG, Severe Optic Neuritis With AQP4-IgG, Longitudinally Extensive Transverse Myelitis (LETM) With AQP4-IgG

9.7. Global Neuromyelitis Optica Spectrum Disorder Market, Sub-Segmentation Of Neuromyelitis Optica Spectrum Disorder Without Aquaporin-4 Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

NMOSD With Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies (MOG-IgG), Seronegative NMOSD, Idiopathic NMOSD Cases, NMOSD Associated With Other Autoimmune Disorders

10. Neuromyelitis Optica Spectrum Disorder Market Regional And Country Analysis

10.1. Global Neuromyelitis Optica Spectrum Disorder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neuromyelitis Optica Spectrum Disorder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuromyelitis Optica Spectrum Disorder Market

11.1. Asia-Pacific Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuromyelitis Optica Spectrum Disorder Market

12.1. China Neuromyelitis Optica Spectrum Disorder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuromyelitis Optica Spectrum Disorder Market

13.1. India Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuromyelitis Optica Spectrum Disorder Market

14.1. Japan Neuromyelitis Optica Spectrum Disorder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuromyelitis Optica Spectrum Disorder Market

15.1. Australia Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuromyelitis Optica Spectrum Disorder Market

16.1. Indonesia Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuromyelitis Optica Spectrum Disorder Market

17.1. South Korea Neuromyelitis Optica Spectrum Disorder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuromyelitis Optica Spectrum Disorder Market

18.1. Taiwan Neuromyelitis Optica Spectrum Disorder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuromyelitis Optica Spectrum Disorder Market

19.1. South East Asia Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuromyelitis Optica Spectrum Disorder Market

20.1. Western Europe Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuromyelitis Optica Spectrum Disorder Market

21.1. UK Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuromyelitis Optica Spectrum Disorder Market

22.1. Germany Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuromyelitis Optica Spectrum Disorder Market

23.1. France Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuromyelitis Optica Spectrum Disorder Market

24.1. Italy Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuromyelitis Optica Spectrum Disorder Market

25.1. Spain Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuromyelitis Optica Spectrum Disorder Market

26.1. Eastern Europe Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuromyelitis Optica Spectrum Disorder Market

27.1. Russia Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuromyelitis Optica Spectrum Disorder Market

28.1. North America Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuromyelitis Optica Spectrum Disorder Market

29.1. USA Neuromyelitis Optica Spectrum Disorder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuromyelitis Optica Spectrum Disorder Market

30.1. Canada Neuromyelitis Optica Spectrum Disorder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuromyelitis Optica Spectrum Disorder Market

31.1. South America Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuromyelitis Optica Spectrum Disorder Market

32.1. Brazil Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuromyelitis Optica Spectrum Disorder Market

33.1. Middle East Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuromyelitis Optica Spectrum Disorder Market

34.1. Africa Neuromyelitis Optica Spectrum Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuromyelitis Optica Spectrum Disorder Market Regulatory and Investment Landscape

36. Neuromyelitis Optica Spectrum Disorder Market Competitive Landscape And Company Profiles

36.1. Neuromyelitis Optica Spectrum Disorder Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neuromyelitis Optica Spectrum Disorder Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neuromyelitis Optica Spectrum Disorder Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Laboratory Corporation of America Holding Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Chugai Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Penn Medicine Overview, Products and Services, Strategy and Financial Analysis

37. Neuromyelitis Optica Spectrum Disorder Market Other Major And Innovative Companies

Genentech Inc, Oregon Health & Science University, Arup Laboratories, Argenx SE, Metropolis Healthcare, Rush University Medical Center, Mitsubishi Tanabe Pharma Corporation, Viela Bio, Alexion Pharmaceuticals, Horizon Therapeutics plc, UCB S.A, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi S.A, Pfizer Inc

38. Global Neuromyelitis Optica Spectrum Disorder Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuromyelitis Optica Spectrum Disorder Market

40. Neuromyelitis Optica Spectrum Disorder Market High Potential Countries, Segments and Strategies

40.1 Neuromyelitis Optica Spectrum Disorder Market In 2030 - Countries Offering Most New Opportunities

40.2 Neuromyelitis Optica Spectrum Disorder Market In 2030 - Segments Offering Most New Opportunities

40.3 Neuromyelitis Optica Spectrum Disorder Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Neuromyelitis Optica Spectrum Disorder Market, Overview Of Key Products - Product Examples
  • Table 2: Global Neuromyelitis Optica Spectrum Disorder Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Neuromyelitis Optica Spectrum Disorder Market, Supply Chain Analysis
  • Table 4: Global Neuromyelitis Optica Spectrum Disorder Market, Major Raw Material Providers
  • Table 5: Global Neuromyelitis Optica Spectrum Disorder Market, Major Resource Providers
  • Table 6: Global Neuromyelitis Optica Spectrum Disorder Market, Major Manufacturers (Suppliers)
  • Table 7: Global Neuromyelitis Optica Spectrum Disorder Market, Major Distributors And Channel Partners
  • Table 8: Global Neuromyelitis Optica Spectrum Disorder Market, Key Technologies & Future Trends
  • Table 9: Global Neuromyelitis Optica Spectrum Disorder Market, Major Trends
  • Table 10: Global Neuromyelitis Optica Spectrum Disorder Market, Major End Users
  • Table 11: Global Neuromyelitis Optica Spectrum Disorder Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Neuromyelitis Optica Spectrum Disorder Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Neuromyelitis Optica Spectrum Disorder Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Neuromyelitis Optica Spectrum Disorder Market - TAM, US$ Billion, 2025
  • Table 15: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Neuromyelitis Optica Spectrum Disorder Market, Sub-Segmentation Of Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Neuromyelitis Optica Spectrum Disorder Market, Sub-Segmentation Of Neuromyelitis Optica Spectrum Disorder Without Aquaporin-4 Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Neuromyelitis Optica Spectrum Disorder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Neuromyelitis Optica Spectrum Disorder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Neuromyelitis Optica Spectrum Disorder Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Neuromyelitis Optica Spectrum Disorder Market - Company Scoring Matrix
  • Table 98: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 99: Laboratory Corporation of America Holding Financial Performance
  • Table 100: Chugai Pharmaceutical Co. Ltd Financial Performance
  • Table 101: Mayo Foundation for Medical Education and Research Financial Performance
  • Table 102: Penn Medicine Financial Performance
  • Table 103: Global Neuromyelitis Optica Spectrum Disorder Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Neuromyelitis Optica Spectrum Disorder Market, Competitive Dashboard
  • Table 105: Global Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 108: Global, Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

List Of Figures

    Figure 1: Global Neuromyelitis Optica Spectrum Disorder Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Neuromyelitis Optica Spectrum Disorder Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Neuromyelitis Optica Spectrum Disorder Market, Supply Chain Analysis
  • Figure 4: Global Neuromyelitis Optica Spectrum Disorder Market, Major Raw Material Providers
  • Figure 5: Global Neuromyelitis Optica Spectrum Disorder Market, Major Resource Providers
  • Figure 6: Global Neuromyelitis Optica Spectrum Disorder Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Neuromyelitis Optica Spectrum Disorder Market, Major Distributors And Channel Partners
  • Figure 8: Global Neuromyelitis Optica Spectrum Disorder Market, Key Technologies & Future Trends
  • Figure 9: Global Neuromyelitis Optica Spectrum Disorder Market, Major Trends
  • Figure 10: Global Neuromyelitis Optica Spectrum Disorder Market, Major End Users
  • Figure 11: Global Neuromyelitis Optica Spectrum Disorder Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Neuromyelitis Optica Spectrum Disorder Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Neuromyelitis Optica Spectrum Disorder Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Neuromyelitis Optica Spectrum Disorder Market - TAM, US$ Billion, 2025
  • Figure 15: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Neuromyelitis Optica Spectrum Disorder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Neuromyelitis Optica Spectrum Disorder Market, Sub-Segmentation Of Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Neuromyelitis Optica Spectrum Disorder Market, Sub-Segmentation Of Neuromyelitis Optica Spectrum Disorder Without Aquaporin-4 Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Neuromyelitis Optica Spectrum Disorder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Neuromyelitis Optica Spectrum Disorder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Neuromyelitis Optica Spectrum Disorder Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Neuromyelitis Optica Spectrum Disorder Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Neuromyelitis Optica Spectrum Disorder Market - Company Scoring Matrix
  • Figure 98: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 99: Laboratory Corporation of America Holding Financial Performance
  • Figure 100: Chugai Pharmaceutical Co. Ltd Financial Performance
  • Figure 101: Mayo Foundation for Medical Education and Research Financial Performance
  • Figure 102: Penn Medicine Financial Performance
  • Figure 103: Global Neuromyelitis Optica Spectrum Disorder Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Neuromyelitis Optica Spectrum Disorder Market, Competitive Dashboard
  • Figure 105: Global Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 108: Global, Neuromyelitis Optica Spectrum Disorder Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Optic Nerve Disorders Treatment Market Report 2026 - Global Outlook – By Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy, Con...

Optic Atrophy Management Market Report 2026 - Global Outlook – By Drug Type (Disulfiram, Amebicides, Ethambutol, Isoniazid, Chloramphenicol, Vincristine, Ciclosporin, Cimetidine), By Route Of Administration (Oral, Inject...

Peripheral Neuropathy Market Report 2026 - Global Outlook – By Type (Chemotherapy-Induced, Diabetic, Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated), Idiopathic), By Diagnosis (...

Retinal Disorder Treatment Market Report 2026 - Global Outlook – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Dis...

Rare Neurological Disease Treatment Market Report 2026 - Global Outlook – By Drug Type (Biologics, Small Molecules), By Therapy (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Disease-Modifying Neurological T...

Neurological Disorder Drugs Market Report 2026 - Global Outlook – By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs C...

Diabetic Neuropathy Market Report 2026 - Global Outlook – By Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), By Drug Class (Analgesics, Anti-Depressants, Anti-Convulsants, O...

Retinal Biologics Market Report 2026 - Global Outlook – By Drug Class (Vascular Endothelial Growth Factor (VEGF)-A Antagonist, Tumor Necrosis Factor (TNF)-A Inhibitor), By Indication (Macular Degeneration, Diabetic Retin...

Frequently Asked Questions

The Neuromyelitis Optica Spectrum Disorder market was valued at $2.54 billion in 2025, increased to $2.76 billion in 2026, and is projected to reach $3.76 billion by 2030.

The global Neuromyelitis Optica Spectrum Disorder market is expected to grow at a CAGR of 8.1% from 2026 to 2035 to reach $3.76 billion by 2035.

Some Key Players in the Neuromyelitis Optica Spectrum Disorder market Include, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holding, Chugai Pharmaceutical Co. Ltd, Mayo Foundation for Medical Education and Research, Penn Medicine, Genentech Inc, Oregon Health & Science University, Arup Laboratories, Argenx SE, Metropolis Healthcare, Rush University Medical Center, Mitsubishi Tanabe Pharma Corporation, Viela Bio, Alexion Pharmaceuticals, Horizon Therapeutics plc, UCB S.A, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi S.A, Pfizer Inc, Eli Lilly and Company, Immune Pharmaceuticals Inc. .

Major trend in this market includes: Advancements In Complement Inhibition Transform NMOSD Treatment Landscape. For further insights on this market. request a sample here

North America was the largest region in the neuromyelitis optica spectrum disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuromyelitis optica spectrum disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us